Alternatives to Elicit

PreDoC is a distributor of drip dispersal septic systems in Pennsylvania. We also provide septic services to residential, commercial, and municipal clients.

An AI-powered search engine that accelerates academic research by extracting and synthesizing findings from over 250 million peer-reviewed papers.

AI workspace for researchers to read, write, and organize research.

AI-powered search and analysis platform for scientific literature and clinical trials.

AI knowledge foundation for regulated enterprises, turning complex data into AI you can trust.

Read any research paper, plainly.

AI-powered research platform for scientific and technical literature.

AI-powered research tool that helps scientists and researchers discover and understand scientific literature.

AI-powered platform automating manual research, data enrichment, and document processing with agentic AI.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-powered drug discovery platform using foundation models for molecular design.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-driven predictive modeling company focused on biology and life sciences.

AI tools for product lifecycle management in medtech and pharma.

Building General Biological Intelligence

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.

AI research institute developing AI systems for scientific discovery and other applications.

A personal AI assistant aiming to deliver proactive, context-aware help across user applications.

AI-powered Digital Brains for professionals and public figures.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

An AI colleague that lives inside Slack to assist with recurring tasks and advance work.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A biotechnology company developing genetic therapies for rare disorders.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Transforms VLM token reduction from irreversible pruning to recoverable routing, improving grounding performance without sacrificing efficiency.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Developing highly targeted, small molecule medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Advancing next-generation mRNA medicines.

AI-powered antibody discovery platform.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.